BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36927117)

  • 1. Management of Acne Vulgaris With Trifarotene.
    Tan J; Chavda R; Baldwin H; Dreno B
    J Cutan Med Surg; 2023; 27(4):368-374. PubMed ID: 36927117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene.
    Aubert J; Piwnica D; Bertino B; Blanchet-Réthoré S; Carlavan I; Déret S; Dreno B; Gamboa B; Jomard A; Luzy AP; Mauvais P; Mounier C; Pascau J; Pelisson I; Portal T; Rivier M; Rossio P; Thoreau E; Vial E; Voegel JJ
    Br J Dermatol; 2018 Aug; 179(2):442-456. PubMed ID: 29974453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Topical Retinoid for Acne: Trifarotene 50 μg/g Cream.
    Tan J; Miklas M
    Skin Therapy Lett; 2020 Mar; 25(2):1-2. PubMed ID: 32196146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trifarotene for the Treatment of Facial and Truncal Acne.
    Bell KA; Brumfiel CM; Haidari W; Boger L
    Ann Pharmacother; 2021 Jan; 55(1):111-116. PubMed ID: 32567361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.
    Blume-Peytavi U; Fowler J; Kemény L; Draelos Z; Cook-Bolden F; Dirschka T; Eichenfield L; Graeber M; Ahmad F; Alió Saenz A; Rich P; Tanghetti E
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):166-173. PubMed ID: 31306527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview on the Management of Atrophic Acne Scars: The Role of Trifarotene as an Adjunct.
    Conte S; Li MK
    Skin Therapy Lett; 2024 Jul; 29(4):1-4. PubMed ID: 38963911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective RAR agonists for acne vulgaris: A narrative review.
    Kassir M; Karagaiah P; Sonthalia S; Katsambas A; Galadari H; Gupta M; Lotti T; Wollina U; Abdelmaksoud A; Grabbe S; Goldust M
    J Cosmet Dermatol; 2020 Jun; 19(6):1278-1283. PubMed ID: 32100454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: Mechanisms of Topical Retinoids in Acne.
    Dreno B; Kang S; Leyden J; York J
    J Drugs Dermatol; 2022 Jul; 21(7):734-740. PubMed ID: 35816067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trifarotene: First Approval.
    Scott LJ
    Drugs; 2019 Nov; 79(17):1905-1909. PubMed ID: 31713811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.
    Tan J; Thiboutot D; Popp G; Gooderham M; Lynde C; Del Rosso J; Weiss J; Blume-Peytavi U; Weglovska J; Johnson S; Parish L; Witkowska D; Sanchez Colon N; Alió Saenz A; Ahmad F; Graeber M; Stein Gold L
    J Am Acad Dermatol; 2019 Jun; 80(6):1691-1699. PubMed ID: 30802558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris.
    Brumfiel CM; Patel MH; Bell KA; Cardis MA
    Ther Clin Risk Manag; 2021; 17():755-763. PubMed ID: 34345173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trifarotene (Aklief) - a new topical retinoid for acne.
    Med Lett Drugs Ther; 2019 Dec; 61(1587):195-197. PubMed ID: 31999666
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical Retinoids in Acne Vulgaris: A Systematic Review.
    Kolli SS; Pecone D; Pona A; Cline A; Feldman SR
    Am J Clin Dermatol; 2019 Jun; 20(3):345-365. PubMed ID: 30674002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trifarotene: A Novel Therapeutic Option for Acne.
    Naik PP
    Dermatol Res Pract; 2022; 2022():1504303. PubMed ID: 35668721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids in Acne Management: Review of Current Understanding, Future Considerations, and Focus on Topical Treatments.
    Chien A
    J Drugs Dermatol; 2018 Dec; 17(12):s51-55. PubMed ID: 30586482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream.
    Eichenfield L; Kwong P; Lee S; Krowchuk D; Arekapudi K; Hebert A
    J Drugs Dermatol; 2022 Jun; 21(6):582-586. PubMed ID: 35674762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKLIEF (Trifarotene 0.005% [50 μg/g] Cream) for Topical Treatment of Acne Vulgaris.
    Gupta AK; Bruce A; Abramovits W; Vincent KD
    Skinmed; 2020; 18(3):160-163. PubMed ID: 32790612
    [No Abstract]   [Full Text] [Related]  

  • 18. 50 Years of Topical Retinoids for Acne: Evolution of Treatment.
    Baldwin H; Webster G; Stein Gold L; Callender V; Cook-Bolden FE; Guenin E
    Am J Clin Dermatol; 2021 May; 22(3):315-327. PubMed ID: 33871811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical retinoids for acne.
    Yeh L; Bonati LM; Silverberg NB
    Semin Cutan Med Surg; 2016 Jun; 35(2):50-6. PubMed ID: 27416308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trifarotene: A Current Review and Perspectives in Dermatology.
    Cosio T; Di Prete M; Gaziano R; Lanna C; Orlandi A; Di Francesco P; Bianchi L; Campione E
    Biomedicines; 2021 Feb; 9(3):. PubMed ID: 33652835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.